[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"grant-the-mark-foundation-for-cancer-research-txbt-and-beyond-aspire-awards-2026":3,"similar-the-mark-foundation-for-cancer-research-txbt-and-beyond-aspire-awards-2026":24},{"id":4,"name":5,"funder":6,"link":7,"budget":8,"budget_min_eur":9,"budget_max_eur":10,"deadline":9,"deadline_note":9,"duration":11,"trl":9,"relevance":9,"why_relevant":9,"early_career":12,"consortium":13,"first_seen":14,"last_updated":9,"update_note":9,"status":15,"stages":9,"call_frequency":9,"next_call_expected":9,"source_url":7,"created_at":16,"updated_at":17,"last_seen_at":16,"eligible_countries":9,"description":18,"seo_summary":19,"recurring_round":12,"canonical_id":4,"links":20},"the-mark-foundation-for-cancer-research-txbt-and-beyond-aspire-awards-2026","TXBT and Beyond ASPIRE Awards","The Mark Foundation for Cancer Research","https:\u002F\u002Fthemarkfoundation.org\u002Ftbxt-and-beyond-aspire-awards-request-for-proposals\u002F","Up to $250,000 (ASPIRE I) or up to $750,000 (ASPIRE II); up to $500,000 for clinical studies",null,645000,"Up to 12 months (ASPIRE I) or up to 36 months (ASPIRE II)",false,"Optional — collaborations are within the scope of the funding mechanism; co-investigators are permitted","2026-11-01T00:00:00.000Z","open","2026-11-01T10:02:15.419Z","2026-11-01T10:02:44.815Z","Joint RFP with the Chordoma Foundation to accelerate development of new strategies targeting the chordoma surfaceome. Open to independent researchers worldwide; supports basic, translational, technology, or clinical research projects.","{\"summary\":\"The TXBT and Beyond ASPIRE Awards, a joint RFP from the Mark Foundation for Cancer Research and the Chordoma Foundation, fund research developing new strategies that target the chordoma surfaceome. Independent researchers worldwide can apply for ASPIRE I (up to $250,000 over 12 months) or ASPIRE II (up to $750,000 over 36 months), covering basic, translational, technology, or clinical research, with clinical studies capped at $500,000.\",\"meta_description\":\"TXBT and Beyond ASPIRE Awards fund chordoma surfaceome research up to $750,000, open to independent researchers worldwide, from the Mark Foundation.\",\"who_should_apply\":[\"Independent researchers worldwide, any career stage\",\"Labs working on chordoma or surfaceome-targeting strategies\",\"Basic, translational, technology, or clinical research projects\",\"Teams proposing clinical studies (capped at $500,000)\",\"Applicants open to optional collaborations or co-investigators\"],\"key_dates\":[\"Two funding tracks: ASPIRE I (up to 12 months) and ASPIRE II (up to 36 months)\"],\"tips\":[\"Frame the project explicitly around the chordoma surfaceome, this is a joint RFP with the Chordoma Foundation, so proposals outside that focus are a poor fit.\",\"Match project scope to track: ASPIRE I suits shorter, focused studies while ASPIRE II supports multi-year programs including clinical work.\",\"If proposing a clinical study, note the $500,000 cap explicitly in your budget justification since it differs from the general ASPIRE II ceiling.\"],\"faq\":[{\"q\":\"How much funding does the ASPIRE Award provide?\",\"a\":\"ASPIRE I awards up to $250,000 over 12 months, ASPIRE II awards up to $750,000 over 36 months, and clinical studies are capped at $500,000.\"},{\"q\":\"Who is eligible for the TXBT and Beyond ASPIRE Awards?\",\"a\":\"Independent researchers anywhere in the world working on chordoma surfaceome-targeting strategies are eligible.\"},{\"q\":\"What type of research does this grant fund?\",\"a\":\"It funds basic, translational, technology, or clinical research aimed at new strategies targeting the chordoma surfaceome.\"},{\"q\":\"Is collaboration required for the ASPIRE Awards?\",\"a\":\"No, collaborations and co-investigators are optional and permitted but not required.\"}],\"tags\":[\"chordoma\",\"cancer-biology\",\"mark-foundation\",\"translational-research\",\"clinical-research\",\"surfaceome\",\"global-eligibility\"]}",{"matchedProgram":9,"resourceSlug":9,"relatedGuides":21,"countryHubs":22,"domainHubs":23,"closingMonth":9,"hasRelated":12,"hasBrowseRelated":12},[],[],[],{"grants":25},[26,30,36,42,46],{"id":27,"name":28,"funder":6,"deadline":9,"budget":29},"the-mark-foundation-for-cancer-research-aspire-i-award-2026","Aspire Award","Up to $250k (ASPIRE I, up to $500k for clinical studies) or up to $750k (ASPIRE II)",{"id":31,"name":32,"funder":33,"deadline":34,"budget":35},"cancer-research-uk-therapeutic-catalyst-target-award-2027-02","Therapeutic Catalyst - Target Award","Cancer Research UK","2027-02-05T00:00:00.000Z","Up to £250K",{"id":37,"name":38,"funder":39,"deadline":40,"budget":41},"cancer-research-institute-impact-grant-2026-12","Impact Grant","Cancer Research Institute","2026-12-01T00:00:00.000Z","$300,000",{"id":43,"name":44,"funder":33,"deadline":34,"budget":45},"cancer-research-uk-therapeutic-catalyst-early-therapy-award-2027-02","Therapeutic Catalyst - Early Therapy Award","Up to £350K",{"id":47,"name":48,"funder":33,"deadline":9,"budget":49},"cancer-research-uk-childhood-cancer-therapeutic-catalyst-2026","Childhood Cancer Therapeutic Catalyst","Up to £250k"]